Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.79
0.112.35%
At close: Dec 15, 4:00 PM EST
$4.79
N/A
After Hours: 4:20 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ:CLLS) through any online brokerage.
Who are Cellectis (CLLS) competitors?
Other companies in Cellectis’s space includes: Galectin Therapeutics Inc (NASDAQ:GALT), Monopar Therapeutics Inc (NASDAQ:MNPR), Immuneering Corp (NASDAQ:IMRX), Altimmune Inc (NASDAQ:ALT) and Prothena Corp PLC (NASDAQ:PRTA).
What is the forecast, or price target, for Cellectis (CLLS) stock?
Cellectis has a consensus price target of $10.00.
What is the current price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $4.79 last updated December 15, 2025 at 4:20 PM EST.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis does not have any upcoming earnings scheduled.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
